These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10921888)

  • 21. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
    Nagl SB; Bunn CF; Allison LA
    J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6.
    Busch K; Martin B; Baniahmad A; Martial JA; Renkawitz R; Muller M
    Mol Endocrinol; 2000 Feb; 14(2):201-11. PubMed ID: 10674394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
    Wade PA; Gegonne A; Jones PL; Ballestar E; Aubry F; Wolffe AP
    Nat Genet; 1999 Sep; 23(1):62-6. PubMed ID: 10471500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple N-CoR complexes contain distinct histone deacetylases.
    Jones PL; Sachs LM; Rouse N; Wade PA; Shi YB
    J Biol Chem; 2001 Mar; 276(12):8807-11. PubMed ID: 11254656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
    Alenghat T; Yu J; Lazar MA
    EMBO J; 2006 Sep; 25(17):3966-74. PubMed ID: 16917504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
    Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
    Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
    Wang L; Hiebert SW
    Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological activity of mammalian transcriptional repressors.
    Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
    Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
    Burke LJ; Downes M; Laudet V; Muscat GE
    Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.
    Xue Y; Wong J; Moreno GT; Young MK; Côté J; Wang W
    Mol Cell; 1998 Dec; 2(6):851-61. PubMed ID: 9885572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A feed-forward repression mechanism anchors the Sin3/histone deacetylase and N-CoR/SMRT corepressors on chromatin.
    Vermeulen M; Walter W; Le Guezennec X; Kim J; Edayathumangalam RS; Lasonder E; Luger K; Roeder RG; Logie C; Berger SL; Stunnenberg HG
    Mol Cell Biol; 2006 Jul; 26(14):5226-36. PubMed ID: 16809761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing nuclear receptors in transcriptional repression.
    Burcin M; Köhne AC; Runge D; Steiner C; Renkawitz R
    Semin Cancer Biol; 1994 Oct; 5(5):337-46. PubMed ID: 7849262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid hormone receptor, v-ErbA, and chromatin.
    Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
    Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
    Tomita A; Buchholz DR; Shi YB
    Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
    Ghysdael J; Beug H
    Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.